IDH1 and central nervous system cancer: TERT promoter mutations are found predominantly in IDH-wildtype glioblastomas and oligodendrogliomas with 1p/19q co-deletion, while they are rare in IDH-mutant astrocytomas, highlighting their diagnostic relevance in differentiating glioma subtypes (13–15).